163 related articles for article (PubMed ID: 38179555)
1. A social profile of deaths related to sickle cell disease in India: a case for an ethical policy response.
Chattoo S; Jain D; Nashine N; Singh R
Front Public Health; 2023; 11():1265313. PubMed ID: 38179555
[TBL] [Abstract][Full Text] [Related]
2. Mortality in sickle cell disease: A population-based study in an aboriginal community in the Gudalur Valley, Nilgiris, Tamil Nadu, India.
Sheshadri V; Shabeer P; Santhirapala V; Jayaram A; Krishnamurti L; Menon N
Pediatr Blood Cancer; 2021 Mar; 68(3):e28875. PubMed ID: 33381914
[TBL] [Abstract][Full Text] [Related]
3. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021.
GBD 2021 Sickle Cell Disease Collaborators
Lancet Haematol; 2023 Aug; 10(8):e585-e599. PubMed ID: 37331373
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
[TBL] [Abstract][Full Text] [Related]
5. Clinical analysis of mortality in hospitalized Zambian children with sickle cell anaemia.
Athale UH; Chintu C
East Afr Med J; 1994 Jun; 71(6):388-91. PubMed ID: 7835262
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.
Dexter D; McGann PT
Pharmacotherapy; 2023 May; 43(5):430-441. PubMed ID: 36906823
[TBL] [Abstract][Full Text] [Related]
7. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
Mano RM; Kuona P; Misihairabgwi JM
BMC Pediatr; 2024 May; 24(1):323. PubMed ID: 38730340
[TBL] [Abstract][Full Text] [Related]
8. Things must not fall apart: the ripple effects of the COVID-19 pandemic on children in sub-Saharan Africa.
Coker M; Folayan MO; Michelow IC; Oladokun RE; Torbunde N; Sam-Agudu NA
Pediatr Res; 2021 Apr; 89(5):1078-1086. PubMed ID: 32971527
[TBL] [Abstract][Full Text] [Related]
9. Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
Dexter D; McGann PT
Br J Haematol; 2022 Jan; 196(1):63-69. PubMed ID: 34340260
[TBL] [Abstract][Full Text] [Related]
10. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
[TBL] [Abstract][Full Text] [Related]
11. Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India.
Upadhye DS; Jain DL; Trivedi YL; Nadkarni AH; Ghosh K; Colah RB
PLoS One; 2016; 11(1):e0147081. PubMed ID: 26785407
[TBL] [Abstract][Full Text] [Related]
12. A call for policy action in sub-Saharan Africa to rethink diagnostics for pregnancy affected by sickle cell disease: differential views of medical doctors, parents and adult patients predict value conflicts in Cameroon.
Wonkam A; Hurst S
OMICS; 2014 Jul; 18(7):472-80. PubMed ID: 24754796
[TBL] [Abstract][Full Text] [Related]
13. Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality.
Makani J; Soka D; Rwezaula S; Krag M; Mghamba J; Ramaiya K; Cox SE; Grosse SD
Trop Med Int Health; 2015 Feb; 20(2):184-7. PubMed ID: 25365928
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
Kuznik A; Habib AG; Munube D; Lamorde M
BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265
[TBL] [Abstract][Full Text] [Related]
16. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
[TBL] [Abstract][Full Text] [Related]
17. Caring for Africa's sickle cell children: will we rise to the challenge?
Oron AP; Chao DL; Ezeanolue EE; Ezenwa LN; Piel FB; Ojogun OT; Uyoga S; Williams TN; Nnodu OE
BMC Med; 2020 Apr; 18(1):92. PubMed ID: 32340612
[TBL] [Abstract][Full Text] [Related]
18. Sickle cell disease in Africa: a neglected cause of early childhood mortality.
Grosse SD; Odame I; Atrash HK; Amendah DD; Piel FB; Williams TN
Am J Prev Med; 2011 Dec; 41(6 Suppl 4):S398-405. PubMed ID: 22099364
[TBL] [Abstract][Full Text] [Related]
19. Characterization of mortality in children with sickle cell disease diagnosed through the Newborn Screening Program.
Sabarense AP; Lima GO; Silva LM; Viana MB
J Pediatr (Rio J); 2015; 91(3):242-7. PubMed ID: 25449790
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study.
Marfo K; Dei-Adomakoh Y; Segbefia C; Dwomoh D; Edgal A; Ampah N; Ramachandrachar BC; Subramanyam K; Natarajan A; Egbujo O; Ataga KI
BMC Health Serv Res; 2023 Sep; 23(1):1018. PubMed ID: 37735428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
